Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer

Nirmish Singla; Ahmed Q. Haddad; Niccolo M. Passoni; Matthew Meissner; Yair Lotan

doi:10.1007/s00345-016-1853-z

Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer

Nirmish Singla, Ahmed Q. Haddad, Niccolo M. Passoni, Matthew Meissner, Yair Lotan

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had

Original language	English (US)
Pages (from-to)	1-7
Number of pages	7
Journal	World Journal of Urology
DOIs	https://doi.org/10.1007/s00345-016-1853-z
State	Accepted/In press - May 18 2016

Keywords

Anti-inflammatory agents
BCG
Intravesical therapy
Non-muscle-invasive bladder cancer

ASJC Scopus subject areas

Urology

Access to Document

10.1007/s00345-016-1853-z

Cite this

@article{4947429e21184bd28be7b15af72e40da,

title = "Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer",

abstract = "Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had ",

keywords = "Anti-inflammatory agents, BCG, Intravesical therapy, Non-muscle-invasive bladder cancer",

author = "Nirmish Singla and Haddad, {Ahmed Q.} and Passoni, {Niccolo M.} and Matthew Meissner and Yair Lotan",

year = "2016",

month = may,

day = "18",

doi = "10.1007/s00345-016-1853-z",

language = "English (US)",

pages = "1--7",

journal = "World Journal of Urology",

issn = "0724-4983",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer

AU - Singla, Nirmish

AU - Haddad, Ahmed Q.

AU - Passoni, Niccolo M.

AU - Meissner, Matthew

AU - Lotan, Yair

PY - 2016/5/18

Y1 - 2016/5/18

N2 - Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had

AB - Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had

KW - Anti-inflammatory agents

KW - BCG

KW - Intravesical therapy

KW - Non-muscle-invasive bladder cancer

UR - http://www.scopus.com/inward/record.url?scp=84969933373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969933373&partnerID=8YFLogxK

U2 - 10.1007/s00345-016-1853-z

DO - 10.1007/s00345-016-1853-z

M3 - Article

C2 - 27194044

AN - SCOPUS:84969933373

SN - 0724-4983

SP - 1

EP - 7

JO - World Journal of Urology

JF - World Journal of Urology

ER -

Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this